The Honorable Al Gore to Deliver Keynote Address at 2010 BIO International Convention
WASHINGTON, D.C. (Wednesday, October 21, 2009) - The Biotechnology Industry Organization (BIO) announced today that Former U.S. Vice President Al Gore will be a keynote speaker at the 2010 BIO International Convention, which will take place May 3-6 at McCormick Place in Chicago, Ill.
Mr. Gore is scheduled to speak on Wednesday, May 5 from 1:00 p.m. to 1:30 p.m. His speech will focus on the environment, healthcare reform and other pressing global issues with an emphasis on biotechnology’s role in addressing these challenges.
"For the past 30 years, Al Gore has been one of the most influential voices on sustainability, climate change and numerous other environmental issues,” said BIO President and CEO James C. Greenwood. "We are honored to have Mr. Gore address our BIO International Convention and share his vision for solving some of the world's most challenging problems through biotechnology innovations that help heal, fuel and feed the world.”
Al Gore served as the 45th Vice President of the United States and continues to advise leaders in Congress and heads of state throughout the world on national and international affairs. Since his earliest days in the U. S. Congress, Al Gore has been the leading advocate for confronting the threat of global warming. In 2007, Mr. Gore received the Nobel Peace Prize for his efforts to reduce global warming.
Mr. Gore is the author of An Inconvenient Truth, a best-selling book on the threat of and solutions to global warming, and the subject of the movie of the same title, which is one of the top documentary films in history.
“Each year, we endeavor to bring the world’s top thought leaders to share their insights and vision with our attendees,” said Robbi Lycett, Vice President of Conventions & Conferences at BIO. “Mr. Gore will continue this tradition of helping cement our Convention’s position as a ‘can’t miss’ event for anyone engaged in the life sciences.”
Wednesday’s keynote session is sponsored by Amgen, a leading human therapeutics company in the biotechnology industry.
In addition to Al Gore's keynote address, presentations and breakout sessions at the 2010 BIO International Convention will focus on research and development, partnership opportunities, and new business models required to meet global health challenges.
The 2010 BIO International Convention is expected to draw between 15,000 and 17,000 industry leaders from 48 states and 60 countries. This year, the Convention program will feature more than 125 sessions in 17 tracks. New tracks for 2010 include Delivery and Manufacturing of Biologics, Global Drug Development and Marketing, Innovations in Vaccines, and MarketPlace Watch.
In addition, this year’s BIO Exhibition will cover an estimated 200,000 net sq. ft. and host more than 1,800 exhibitors. Product Focus Zones within the BIO Exhibition will include BioProcess, Business Services, Clinical Trials, Contracts, Discovery and the BioPark.
The BIO International Convention helps to support BIO programs and initiatives. BIO works throughout the year to create a policy environment that enables the industry to continue to fulfill its vision of bettering the world through biotechnology innovation. For more information on the global event for biotechnology, including program and housing information, please visit http://convention.bio.org/.
Upcoming BIO Events
BIO Intellectual Property Counsels Fall Conference and Committee Meeting
October 26-28, 2009
BIO Investor Forum
October 28-29, 2009
San Francisco, CA
Advanced Business Development Course
October 30, 2009
BIO Europe International Partnering Conference
November 2-4, 2009
Pacific Rim Summit on Industrial Biotechnology and Bioenergy
November 8-11, 2009
January 25-26, 2010
February 8-9, 2010
New York, NY
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.